Shijiazhuang Yiling Pharmaceutical Co., Ltd. (SHE:002603)
China
· Delayed Price · Currency is CNY 14.16
+0.30 (2.16%)
May 12, 2025, 2:45 PM CST
SHE:002603 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | -702.49 | -724.52 | 1,352 | 2,363 | 1,344 | 1,219 | Upgrade
|
Depreciation & Amortization | 610.65 | 610.65 | 548.52 | 451.47 | 362.93 | 268.16 | Upgrade
|
Other Amortization | 3.4 | 3.4 | 0.95 | 0.66 | 4.85 | 6.78 | Upgrade
|
Loss (Gain) From Sale of Assets | 0.49 | 0.49 | 0.82 | 3.11 | 2.52 | -0.14 | Upgrade
|
Asset Writedown & Restructuring Costs | 7 | 7 | 11.15 | 95.62 | 10.76 | 53.12 | Upgrade
|
Loss (Gain) From Sale of Investments | -44.87 | -44.87 | -78.08 | -11.5 | -4.42 | -29.6 | Upgrade
|
Provision & Write-off of Bad Debts | 10.54 | 10.54 | 22.21 | 16.62 | 36.93 | 5.04 | Upgrade
|
Other Operating Activities | 460.7 | 259.64 | 58.6 | 44.94 | 51.24 | 21.63 | Upgrade
|
Change in Accounts Receivable | 638.25 | 638.25 | -700.49 | -831.66 | -1,280 | -668.73 | Upgrade
|
Change in Inventory | 470.32 | 470.32 | -459.67 | -348.01 | -104.74 | -364.91 | Upgrade
|
Change in Accounts Payable | -447.3 | -447.3 | -722.76 | 1,886 | 55.15 | 1,126 | Upgrade
|
Change in Other Net Operating Assets | 25.55 | 25.55 | 17.35 | -22.82 | 29.75 | 17.67 | Upgrade
|
Operating Cash Flow | 834.11 | 611.01 | 155.46 | 3,488 | 528.69 | 1,586 | Upgrade
|
Operating Cash Flow Growth | - | 293.04% | -95.54% | 559.69% | -66.67% | 2201.29% | Upgrade
|
Capital Expenditures | -266.27 | -290.39 | -310.83 | -213.98 | -673.56 | -1,145 | Upgrade
|
Sale of Property, Plant & Equipment | 0.02 | 0.02 | 0.97 | 0.35 | 1.2 | 0.3 | Upgrade
|
Cash Acquisitions | - | - | -676.29 | - | - | - | Upgrade
|
Investment in Securities | 1,498 | 1,785 | 49.1 | -1,789 | 159.33 | 78.94 | Upgrade
|
Other Investing Activities | 104.18 | 117.4 | 37.83 | 7.66 | 6.28 | 25.34 | Upgrade
|
Investing Cash Flow | 1,336 | 1,612 | -899.22 | -1,995 | -506.76 | -1,040 | Upgrade
|
Short-Term Debt Issued | - | 282 | 500 | - | - | - | Upgrade
|
Long-Term Debt Issued | - | 870 | 1,200 | 1,850 | 2,400 | 489.98 | Upgrade
|
Total Debt Issued | 752 | 1,152 | 1,700 | 1,850 | 2,400 | 489.98 | Upgrade
|
Short-Term Debt Repaid | - | -782 | -393 | - | - | - | Upgrade
|
Long-Term Debt Repaid | - | -2,277 | -654.82 | -2,204 | -1,483 | -269.98 | Upgrade
|
Total Debt Repaid | -2,658 | -3,059 | -1,048 | -2,204 | -1,483 | -269.98 | Upgrade
|
Net Debt Issued (Repaid) | -1,906 | -1,907 | 652.18 | -354.3 | 916.81 | 220 | Upgrade
|
Issuance of Common Stock | 30.5 | 30.5 | - | - | - | - | Upgrade
|
Common Dividends Paid | -367.41 | -375.31 | -872.77 | -282.7 | -1,220 | -244.1 | Upgrade
|
Other Financing Activities | -80.86 | -1.32 | - | - | 1.18 | 0.84 | Upgrade
|
Financing Cash Flow | -2,323 | -2,253 | -220.59 | -637 | -302.15 | -23.26 | Upgrade
|
Foreign Exchange Rate Adjustments | 0.18 | 0.11 | 0.33 | 1.25 | -0.48 | -1.95 | Upgrade
|
Net Cash Flow | -152.86 | -30.03 | -964.03 | 857.18 | -280.69 | 520.76 | Upgrade
|
Free Cash Flow | 567.83 | 320.62 | -155.38 | 3,274 | -144.87 | 441.39 | Upgrade
|
Free Cash Flow Margin | 8.95% | 4.92% | -1.51% | 26.12% | -1.43% | 5.03% | Upgrade
|
Free Cash Flow Per Share | 0.34 | 0.19 | -0.09 | 1.96 | -0.09 | 0.26 | Upgrade
|
Cash Income Tax Paid | 638.5 | 711.26 | 1,324 | 1,322 | 1,174 | 1,162 | Upgrade
|
Levered Free Cash Flow | 726.09 | 656.46 | 102.54 | 3,670 | 251.91 | 1,364 | Upgrade
|
Unlevered Free Cash Flow | 738.34 | 674.59 | 126.86 | 3,691 | 273.14 | 1,371 | Upgrade
|
Change in Net Working Capital | -896.22 | -874.06 | 1,120 | -1,669 | 370.29 | -1,349 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.